-
Mylan to acquire Renaissance’s specialty, generics businesses
PITTSBURGH — Mylan on Thursday announced the planned acquisition of Renaissance Acquisition Holdings’ specialty and generics businesses, which are focused on topical treatments. The deal will see Mylan paying $950 million in cash at closing, as well as additional contingent payments up to $50 million based on customary adjustments.Benzer Pharmacy receives full URAC specialty accreditation
AUBURNDALE, Fla. — Benzer Pharmacy on Wednesday announced that it had received specialty pharmacy accreditation from the Utilization Review Accreditation Commission (URAC).“Achieving the specialty accreditation from URAC reaffirms our company’s dedication to consistency and excellence in delivering great services as the pharmacy is projected to grow rapidly in order to reach more customers and to make sure their experiences match their expectations,” Benzer Pharmacy president Alpesh Patel said.